Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized sequencing study of Japanese encephalitis and yellow fever vaccines
ACTRN12625000742471Phase 2Recruiting
- Sponsor
- University of Melbourne
- Start
- Oct 2025
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of 17D yellow fever vaccine and Japanese encephalitis vaccine in yellow fever and Japanese encephalitis (JE) (2 arms), sponsored by University of Melbourne. Started Oct 2025; status: recruiting.
02
Drugs
17D yellow fever vaccineJapanese encephalitis vaccine
03
Conditions
yellow feverJapanese encephalitis (JE)
Beyond the preview
Go deeper on ACTRN12625000742471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000742471.